NCT07671729 Quadriceps Tendon vs Peroneus Longus Tendon in ACL Reconstruction
| NCT ID | NCT07671729 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acibadem University |
| Condition | Anterior Cruciate Ligament Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-05-01 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized clinical trial aims to compare quadriceps tendon and peroneus longus tendon autografts in anterior cruciate ligament reconstruction. Patients with anterior cruciate ligament injury undergoing primary reconstruction surgery will be randomly assigned to one of the two graft groups. Clinical examination findings, return-to-sport outcomes, ankle muscle strength, ankle-related functional scores, and gait analysis parameters will be evaluated at 6 months and 12 months postoperatively. The study aims to investigate both knee-related functional outcomes and donor site morbidity associated with graft harvesting techniques.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with anterior cruciate ligament rupture * Patients scheduled for primary anterior cruciate ligament reconstruction * Age between 18 and 50 years * Ability to provide informed consent * Willingness to comply with postoperative rehabilitation and follow-up evaluations Exclusion Criteria: * Previous ligament reconstruction surgery on the affected knee * Multi-ligament knee injuries requiring additional ligament reconstruction * Severe osteoarthritis of the knee * Revision anterior cruciate ligament reconstruction * Neuromuscular disorders affecting lower extremity function * Active infection * Inability to comply with follow-up protocol
Frequently Asked Questions
Who can join the NCT07671729 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Anterior Cruciate Ligament Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07671729 currently recruiting?
Yes, NCT07671729 is actively recruiting participants. Visit ClinicalTrials.gov or contact Acibadem University to inquire about joining.
Where is the NCT07671729 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07671729 clinical trial?
NCT07671729 is sponsored by Acibadem University. The trial plans to enroll 60 participants.